Recro Pharma to Present at Upcoming Investor Conferences

MALVERN, Pa., March 02, 2017 — Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently developing non-opioid products for the treatment of serious acute pain, today announced that Gerri Henwood, the Companys President and Chief Executive Officer, will present at the following upcoming investor conferences: The Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 11:20 am ET at the Boston Marriott Copley Place.   The 29th Annual ROTH Conference on Tuesday, March 14, 2017 at 2:30 pm PT at the Ritz Carlton Laguna Niguel in Dana Point.